Gaboxadol Normalizes Behavioral Abnormalities in a Mouse Model of Fragile X Syndrome.

In Fmr1 KO2 mice treated with 1.5 and 4.0 mg/kg gaboxadol, mounting behavior did not differ significantly from WT-vehicle treated mice, suggesting a trend for an effect at these doses even though their comparison to the KO-vehicle treated group did not reach statistical significance ( Figure 3C ).

also in 111,027 other papers